APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nasal Drug Delivery Technology

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nasal Drug Delivery Technology Market Outlook and Growth Opportunities 2026

22 December 2025200 pages

Choose your research edition.

Industry ResearchNasal Drug Delivery Technology Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Nasal Drug Delivery Technology Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Nasal Drug Delivery Technology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nasal Drug Delivery Technology Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Nasal Drug Delivery Technology Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Nasal Drug Delivery Technology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nasal Drug Delivery Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nasal Drug Delivery Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nasal Drug Delivery Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nasal Drug Delivery Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nasal Drug Delivery Technology market include Johnson & Johnson, Novartis AG, Merck & Co., Inc., Pfizer, Inc, Shin Nippon Biomedical Laboratories, Promius Pharma, LLC, PendoPharm, Inc, OptiNose, Inc and Glaxosmithkline PLC, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Nasal Drug Delivery Technology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nasal Drug Delivery Technology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nasal Drug Delivery Technology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Nasal Drug Delivery Technology market.

Nasal Drug Delivery Technology Segment by Company

Johnson & Johnson

Novartis AG

Merck & Co., Inc.

Pfizer, Inc

Shin Nippon Biomedical Laboratories

Promius Pharma, LLC

PendoPharm, Inc

OptiNose, Inc

Glaxosmithkline PLC

ENT Technologies Pty. Ltd

Douglas Pharmaceuticals Ltd

Dickinson and Company

Cadila Pharmaceuticals Ltd

BF Ascher & Company, Inc.

Becton, Dickinson and Company

Aptargroup, Inc.

Aegis Therapeutics LLC

3M United States

Nasal Drug Delivery Technology Segment by Type

Pressurized Type

Non-pressurized Type

Nasal Drug Delivery Technology Segment by Application

Asthma

Rhinitis

Nasal Congestion

Other

Nasal Drug Delivery Technology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nasal Drug Delivery Technology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Nasal Drug Delivery Technology key companies, revenue, market share, and recent developments.

3. To split the Nasal Drug Delivery Technology breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Nasal Drug Delivery Technology market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nasal Drug Delivery Technology significant trends, drivers, influence factors in global and regions.

6. To analyze Nasal Drug Delivery Technology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nasal Drug Delivery Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nasal Drug Delivery Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nasal Drug Delivery Technology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nasal Drug Delivery Technology industry.

Chapter 3: Detailed analysis of Nasal Drug Delivery Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Nasal Drug Delivery Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Nasal Drug Delivery Technology in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nasal Drug Delivery Technology Industry Trends Table 2. Nasal Drug Delivery Technology Industry Drivers Table 3. Nasal Drug Delivery Technology Industry Opportunities and Challenges Table 4. Nasal Drug Delivery Technology Industry Restraints Table 5. Global Nasal Drug Delivery Technology Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nasal Drug Delivery Technology Revenue Share by Company (2021-2026) Table 7. Global Nasal Drug Delivery Technology Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Nasal Drug Delivery Technology Key Company Manufacturing Base & Headquarters Table 9. Global Nasal Drug Delivery Technology Company, Product Type & Application Table 10. Global Nasal Drug Delivery Technology Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Nasal Drug Delivery Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Pressurized Type Table 15. Significant Companies of Non-pressurized Type Table 16. Global Nasal Drug Delivery Technology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Nasal Drug Delivery Technology Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Nasal Drug Delivery Technology Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Nasal Drug Delivery Technology Sales Value Share by Type (2021-2026) Table 20. Global Nasal Drug Delivery Technology Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Asthma Table 22. Significant Companies of Rhinitis Table 23. Significant Companies of Nasal Congestion Table 24. Significant Companies of Other Table 25. Global Nasal Drug Delivery Technology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Nasal Drug Delivery Technology Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Nasal Drug Delivery Technology Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Nasal Drug Delivery Technology Sales Value Share by Application (2021-2026) Table 29. Global Nasal Drug Delivery Technology Sales Value Share by Application (2027-2032) Table 30. Global Nasal Drug Delivery Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Nasal Drug Delivery Technology Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Nasal Drug Delivery Technology Sales Value Share by Region (2021-2026) Table 33. Global Nasal Drug Delivery Technology Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Nasal Drug Delivery Technology Sales Value Share by Region (2027-2032) Table 35. Global Nasal Drug Delivery Technology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Nasal Drug Delivery Technology Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Nasal Drug Delivery Technology Sales Value Market Share by Country (2021-2026) Table 38. Global Nasal Drug Delivery Technology Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Nasal Drug Delivery Technology Sales Value Market Share by Country (2027-2032) Table 40. Johnson & Johnson Company Information Table 41. Johnson & Johnson Business Overview Table 42. Johnson & Johnson Nasal Drug Delivery Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Johnson & Johnson Nasal Drug Delivery Technology Product Portfolio Table 44. Johnson & Johnson Recent Development Table 45. Novartis AG Company Information Table 46. Novartis AG Business Overview Table 47. Novartis AG Nasal Drug Delivery Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Novartis AG Nasal Drug Delivery Technology Product Portfolio Table 49. Novartis AG Recent Development Table 50. Merck & Co., Inc. Company Information Table 51. Merck & Co., Inc. Business Overview Table 52. Merck & Co., Inc. Nasal Drug Delivery Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Merck & Co., Inc. Nasal Drug Delivery Technology Product Portfolio Table 54. Merck & Co., Inc. Recent Development Table 55. Pfizer, Inc Company Information Table 56. Pfizer, Inc Business Overview Table 57. Pfizer, Inc Nasal Drug Delivery Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Pfizer, Inc Nasal Drug Delivery Technology Product Portfolio Table 59. Pfizer, Inc Recent Development Table 60. Shin Nippon Biomedical Laboratories Company Information Table 61. Shin Nippon Biomedical Laboratories Business Overview Table 62. Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Product Portfolio Table 64. Shin Nippon Biomedical Laboratories Recent Development Table 65. Promius Pharma, LLC Company Information Table 66. Promius Pharma, LLC Business Overview Table 67. Promius Pharma, LLC Nasal Drug Delivery Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Promius Pharma, LLC Nasal Drug Delivery Technology Product Portfolio Table 69. Promius Pharma, LLC Recent Development Table 70. PendoPharm, Inc Company Information Table 71. PendoPharm, Inc Business Overview Table 72. PendoPharm, Inc Nasal Drug Delivery Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. PendoPharm, Inc Nasal Drug Delivery Technology Product Portfolio Table 74. PendoPharm, Inc Recent Development Table 75. OptiNose, Inc Company Information Table 76. OptiNose, Inc Business Overview Table 77. OptiNose, Inc Nasal Drug Delivery Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. OptiNose, Inc Nasal Drug Delivery Technology Product Portfolio Table 79. OptiNose, Inc Recent Development Table 80. Glaxosmithkline PLC Company Information Table 81. Glaxosmithkline PLC Business Overview Table 82. Glaxosmithkline PLC Nasal Drug Delivery Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Glaxosmithkline PLC Nasal Drug Delivery Technology Product Portfolio Table 84. Glaxosmithkline PLC Recent Development Table 85. ENT Technologies Pty. Ltd Company Information Table 86. ENT Technologies Pty. Ltd Business Overview Table 87. ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Product Portfolio Table 89. ENT Technologies Pty. Ltd Recent Development Table 90. Douglas Pharmaceuticals Ltd Company Information Table 91. Douglas Pharmaceuticals Ltd Business Overview Table 92. Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Portfolio Table 94. Douglas Pharmaceuticals Ltd Recent Development Table 95. Dickinson and Company Company Information Table 96. Dickinson and Company Business Overview Table 97. Dickinson and Company Nasal Drug Delivery Technology Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Dickinson and Company Nasal Drug Delivery Technology Product Portfolio Table 99. Dickinson and Company Recent Development Table 100. Cadila Pharmaceuticals Ltd Company Information Table 101. Cadila Pharmaceuticals Ltd Business Overview Table 102. Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Portfolio Table 104. Cadila Pharmaceuticals Ltd Recent Development Table 105. BF Ascher & Company, Inc. Company Information Table 106. BF Ascher & Company, Inc. Business Overview Table 107. BF Ascher & Company, Inc. Nasal Drug Delivery Technology Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. BF Ascher & Company, Inc. Nasal Drug Delivery Technology Product Portfolio Table 109. BF Ascher & Company, Inc. Recent Development Table 110. Becton, Dickinson and Company Company Information Table 111. Becton, Dickinson and Company Business Overview Table 112. Becton, Dickinson and Company Nasal Drug Delivery Technology Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Becton, Dickinson and Company Nasal Drug Delivery Technology Product Portfolio Table 114. Becton, Dickinson and Company Recent Development Table 115. Aptargroup, Inc. Company Information Table 116. Aptargroup, Inc. Business Overview Table 117. Aptargroup, Inc. Nasal Drug Delivery Technology Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Aptargroup, Inc. Nasal Drug Delivery Technology Product Portfolio Table 119. Aptargroup, Inc. Recent Development Table 120. Aegis Therapeutics LLC Company Information Table 121. Aegis Therapeutics LLC Business Overview Table 122. Aegis Therapeutics LLC Nasal Drug Delivery Technology Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Aegis Therapeutics LLC Nasal Drug Delivery Technology Product Portfolio Table 124. Aegis Therapeutics LLC Recent Development Table 125. 3M United States Company Information Table 126. 3M United States Business Overview Table 127. 3M United States Nasal Drug Delivery Technology Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. 3M United States Nasal Drug Delivery Technology Product Portfolio Table 129. 3M United States Recent Development Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Nasal Drug Delivery Technology Product Image Figure 2. Global Nasal Drug Delivery Technology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 4. Global Nasal Drug Delivery Technology Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Pressurized Type Image Figure 8. Non-pressurized Type Image Figure 9. Global Nasal Drug Delivery Technology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Nasal Drug Delivery Technology Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Nasal Drug Delivery Technology Sales Value Share by Type (2021-2032) Figure 12. Asthma Image Figure 13. Rhinitis Image Figure 14. Nasal Congestion Image Figure 15. Other Image Figure 16. Global Nasal Drug Delivery Technology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Nasal Drug Delivery Technology Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Nasal Drug Delivery Technology Sales Value Share by Application (2021-2032) Figure 19. Global Nasal Drug Delivery Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Nasal Drug Delivery Technology Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Nasal Drug Delivery Technology Sales Value (2021-2032) & (US$ Million) Figure 22. North America Nasal Drug Delivery Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Nasal Drug Delivery Technology Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Nasal Drug Delivery Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Nasal Drug Delivery Technology Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Nasal Drug Delivery Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Nasal Drug Delivery Technology Sales Value (2021-2032) & (US$ Million) Figure 28. South America Nasal Drug Delivery Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Nasal Drug Delivery Technology Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Nasal Drug Delivery Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Pressurized Type
  • Non-pressurized Type
Applications
  • Asthma
  • Rhinitis
  • Nasal Congestion
  • Other
Companies covered
  • Johnson & Johnson
  • Novartis AG
  • Merck & Co., Inc.
  • Pfizer, Inc
  • Shin Nippon Biomedical Laboratories
  • Promius Pharma, LLC
  • PendoPharm, Inc
  • OptiNose, Inc
  • Glaxosmithkline PLC
  • ENT Technologies Pty. Ltd
  • Douglas Pharmaceuticals Ltd
  • Dickinson and Company
  • Cadila Pharmaceuticals Ltd
  • BF Ascher & Company, Inc.
  • Becton, Dickinson and Company
  • Aptargroup, Inc.
  • Aegis Therapeutics LLC
  • 3M United States

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nasal Drug Delivery Technology Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nasal Drug Delivery Technology Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Nasal Drug Delivery Technology Market Dynamics
  1. 2.1 Nasal Drug Delivery Technology Industry Trends
  2. 2.2 Nasal Drug Delivery Technology Industry Drivers
  3. 2.3 Nasal Drug Delivery Technology Industry Opportunities and Challenges
  4. 2.4 Nasal Drug Delivery Technology Industry Restraints
3 Nasal Drug Delivery Technology Market by Company
  1. 3.1 Global Nasal Drug Delivery Technology Company Revenue Ranking in 2025
  2. 3.2 Global Nasal Drug Delivery Technology Revenue by Company (2021-2026)
  3. 3.3 Global Nasal Drug Delivery Technology Company Ranking (2024-2026)
  4. 3.4 Global Nasal Drug Delivery Technology Company Manufacturing Base and Headquarters
  5. 3.5 Global Nasal Drug Delivery Technology Company Product Type and Application
  6. 3.6 Global Nasal Drug Delivery Technology Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Nasal Drug Delivery Technology Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Nasal Drug Delivery Technology Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Nasal Drug Delivery Technology Market by Type
  1. 4.1 Nasal Drug Delivery Technology Type Introduction
  2. 4.1.1 Pressurized Type
  3. 4.1.2 Non-pressurized Type
  4. 4.2 Global Nasal Drug Delivery Technology Sales Value by Type
  5. 4.2.1 Global Nasal Drug Delivery Technology Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nasal Drug Delivery Technology Sales Value by Type (2021-2032)
  7. 4.2.3 Global Nasal Drug Delivery Technology Sales Value Share by Type (2021-2032)
5 Nasal Drug Delivery Technology Market by Application
  1. 5.1 Nasal Drug Delivery Technology Application Introduction
  2. 5.1.1 Asthma
  3. 5.1.2 Rhinitis
  4. 5.1.3 Nasal Congestion
  5. 5.1.4 Other
  6. 5.2 Global Nasal Drug Delivery Technology Sales Value by Application
  7. 5.2.1 Global Nasal Drug Delivery Technology Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Nasal Drug Delivery Technology Sales Value by Application (2021-2032)
  9. 5.2.3 Global Nasal Drug Delivery Technology Sales Value Share by Application (2021-2032)
6 Nasal Drug Delivery Technology Regional Value Analysis
  1. 6.1 Global Nasal Drug Delivery Technology Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nasal Drug Delivery Technology Sales Value by Region (2021-2032)
  3. 6.2.1 Global Nasal Drug Delivery Technology Sales Value by Region: 2021-2026
  4. 6.2.2 Global Nasal Drug Delivery Technology Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nasal Drug Delivery Technology Sales Value (2021-2032)
  7. 6.3.2 North America Nasal Drug Delivery Technology Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Nasal Drug Delivery Technology Sales Value (2021-2032)
  10. 6.4.2 Europe Nasal Drug Delivery Technology Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Nasal Drug Delivery Technology Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Nasal Drug Delivery Technology Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Nasal Drug Delivery Technology Sales Value (2021-2032)
  16. 6.6.2 South America Nasal Drug Delivery Technology Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Nasal Drug Delivery Technology Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Nasal Drug Delivery Technology Sales Value Share by Country, 2025 VS 2032
7 Nasal Drug Delivery Technology Country-level Value Analysis
  1. 7.1 Global Nasal Drug Delivery Technology Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nasal Drug Delivery Technology Sales Value by Country (2021-2032)
  3. 7.2.1 Global Nasal Drug Delivery Technology Sales Value by Country (2021-2026)
  4. 7.2.2 Global Nasal Drug Delivery Technology Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Nasal Drug Delivery Technology Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Nasal Drug Delivery Technology Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Nasal Drug Delivery Technology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Nasal Drug Delivery Technology Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Nasal Drug Delivery Technology Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 Merck & Co., Inc.
  14. 8.3.1 Merck & Co., Inc. Company Information
  15. 8.3.2 Merck & Co., Inc. Business Overview
  16. 8.3.3 Merck & Co., Inc. Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck & Co., Inc. Nasal Drug Delivery Technology Product Portfolio
  18. 8.3.5 Merck & Co., Inc. Recent Developments
  19. 8.4 Pfizer, Inc
  20. 8.4.1 Pfizer, Inc Company Information
  21. 8.4.2 Pfizer, Inc Business Overview
  22. 8.4.3 Pfizer, Inc Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer, Inc Nasal Drug Delivery Technology Product Portfolio
  24. 8.4.5 Pfizer, Inc Recent Developments
  25. 8.5 Shin Nippon Biomedical Laboratories
  26. 8.5.1 Shin Nippon Biomedical Laboratories Company Information
  27. 8.5.2 Shin Nippon Biomedical Laboratories Business Overview
  28. 8.5.3 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Product Portfolio
  30. 8.5.5 Shin Nippon Biomedical Laboratories Recent Developments
  31. 8.6 Promius Pharma, LLC
  32. 8.6.1 Promius Pharma, LLC Company Information
  33. 8.6.2 Promius Pharma, LLC Business Overview
  34. 8.6.3 Promius Pharma, LLC Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Promius Pharma, LLC Nasal Drug Delivery Technology Product Portfolio
  36. 8.6.5 Promius Pharma, LLC Recent Developments
  37. 8.7 PendoPharm, Inc
  38. 8.7.1 PendoPharm, Inc Company Information
  39. 8.7.2 PendoPharm, Inc Business Overview
  40. 8.7.3 PendoPharm, Inc Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PendoPharm, Inc Nasal Drug Delivery Technology Product Portfolio
  42. 8.7.5 PendoPharm, Inc Recent Developments
  43. 8.8 OptiNose, Inc
  44. 8.8.1 OptiNose, Inc Company Information
  45. 8.8.2 OptiNose, Inc Business Overview
  46. 8.8.3 OptiNose, Inc Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  47. 8.8.4 OptiNose, Inc Nasal Drug Delivery Technology Product Portfolio
  48. 8.8.5 OptiNose, Inc Recent Developments
  49. 8.9 Glaxosmithkline PLC
  50. 8.9.1 Glaxosmithkline PLC Company Information
  51. 8.9.2 Glaxosmithkline PLC Business Overview
  52. 8.9.3 Glaxosmithkline PLC Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Glaxosmithkline PLC Nasal Drug Delivery Technology Product Portfolio
  54. 8.9.5 Glaxosmithkline PLC Recent Developments
  55. 8.10 ENT Technologies Pty. Ltd
  56. 8.10.1 ENT Technologies Pty. Ltd Company Information
  57. 8.10.2 ENT Technologies Pty. Ltd Business Overview
  58. 8.10.3 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Product Portfolio
  60. 8.10.5 ENT Technologies Pty. Ltd Recent Developments
  61. 8.11 Douglas Pharmaceuticals Ltd
  62. 8.11.1 Douglas Pharmaceuticals Ltd Company Information
  63. 8.11.2 Douglas Pharmaceuticals Ltd Business Overview
  64. 8.11.3 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Portfolio
  66. 8.11.5 Douglas Pharmaceuticals Ltd Recent Developments
  67. 8.12 Dickinson and Company
  68. 8.12.1 Dickinson and Company Company Information
  69. 8.12.2 Dickinson and Company Business Overview
  70. 8.12.3 Dickinson and Company Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dickinson and Company Nasal Drug Delivery Technology Product Portfolio
  72. 8.12.5 Dickinson and Company Recent Developments
  73. 8.13 Cadila Pharmaceuticals Ltd
  74. 8.13.1 Cadila Pharmaceuticals Ltd Company Information
  75. 8.13.2 Cadila Pharmaceuticals Ltd Business Overview
  76. 8.13.3 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Portfolio
  78. 8.13.5 Cadila Pharmaceuticals Ltd Recent Developments
  79. 8.14 BF Ascher & Company, Inc.
  80. 8.14.1 BF Ascher & Company, Inc. Company Information
  81. 8.14.2 BF Ascher & Company, Inc. Business Overview
  82. 8.14.3 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Product Portfolio
  84. 8.14.5 BF Ascher & Company, Inc. Recent Developments
  85. 8.15 Becton, Dickinson and Company
  86. 8.15.1 Becton, Dickinson and Company Company Information
  87. 8.15.2 Becton, Dickinson and Company Business Overview
  88. 8.15.3 Becton, Dickinson and Company Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Becton, Dickinson and Company Nasal Drug Delivery Technology Product Portfolio
  90. 8.15.5 Becton, Dickinson and Company Recent Developments
  91. 8.16 Aptargroup, Inc.
  92. 8.16.1 Aptargroup, Inc. Company Information
  93. 8.16.2 Aptargroup, Inc. Business Overview
  94. 8.16.3 Aptargroup, Inc. Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Aptargroup, Inc. Nasal Drug Delivery Technology Product Portfolio
  96. 8.16.5 Aptargroup, Inc. Recent Developments
  97. 8.17 Aegis Therapeutics LLC
  98. 8.17.1 Aegis Therapeutics LLC Company Information
  99. 8.17.2 Aegis Therapeutics LLC Business Overview
  100. 8.17.3 Aegis Therapeutics LLC Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Aegis Therapeutics LLC Nasal Drug Delivery Technology Product Portfolio
  102. 8.17.5 Aegis Therapeutics LLC Recent Developments
  103. 8.18 3M United States
  104. 8.18.1 3M United States Company Information
  105. 8.18.2 3M United States Business Overview
  106. 8.18.3 3M United States Nasal Drug Delivery Technology Revenue and Gross Margin (2021-2026)
  107. 8.18.4 3M United States Nasal Drug Delivery Technology Product Portfolio
  108. 8.18.5 3M United States Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst